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Abstract. Alleles of the apolipoprotein E (ApoE) gene are known to modulate the genetic risk for developing late-onset
Alzheimer’s disease (AD) and have been associated with hippocampal volume differences in AD. However, the effect of these
alleles on hippocampal volume in younger subjects has yet to be clearly established. Using a large cohort of more than 1,400
adolescents, this study found no hippocampal volume or hippocampal asymmetry differences between carriers and non-carriers
of the ApoE 4 or 2 alleles, nor dose-dependent effects of either allele, suggesting that regionally specific effects of these
polymorphisms may only become apparent in later life.
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INTRODUCTION
The hippocampus has a key role in Alzheimer’s
disease (AD) and is among one of the first brain
regions to show characteristic signs of neurofib-
rillary tangle pathology, which can be observed
pre-symptomatically in adults as young as 20 years
[1, 2]. Although hippocampal atrophy is commonly
seen in AD, studies have also demonstrated lower hip-
pocampal volumes in healthy older adults and amnestic
mild cognitive impairment subjects (MCI) [3–6].
The presence of the apolipoprotein (ApoE) 4 allele
is a major genetic risk factor for the development of
late onset AD [7–9], whereas possession of the 2
allele has been suggested to confer a protective effect
against the disease [10, 11]. Healthy adult carriers of
the ApoE 4 allele may be more vulnerable to degen-
eration of the hippocampus as they enter middle age
[12, 13], and show altered patterns of brain activity
in response to non-verbal stimuli [14]. A recent study
has also demonstrated that homozygous ApoE4 carri-
ers (4/4) may demonstrate wider patterns of cortical
atrophy than heterozygous carriers (4/no 4), thus
suggesting a possible 4 allele dose-dependent effect
[15]. However, a small number of studies have failed to
replicate these findings [12, 16], and others have con-
versely reported advantageous effects of the ApoE 4
genotype in young individuals [17].
Less work has addressed the effect of ApoE poly-
morphisms in healthy children and adolescents, and the
core aspects of neuronal development in these indi-
viduals are less clear. ApoE 2 allele carriers stave
off the effects of AD [18, 19], but whether proper-
ties of the 2 allele could have a positive effect on
neuronal development in adolescence remains largely
unexplored. Using a cohort of 1,412 adolescents from
the IMAGEN study, we examined the possibility that
the 4 and 2 alleles may affect hippocampal volume
in adolescents, and either render them at risk or protect
them from future age-related neurodegeneration.
MATERIALS AND METHOD
Healthy adolescents were studied from the European
multi-center neuroimaging-genetics IMAGEN project
[20]. A total of 1,412 adolescents had ApoE genotype
available.
MR images were acquired using 3T MRI sys-
tems from major MR manufacturers (Siemens, Philips,
Bruker, and General Electric). A standardized imag-
ing protocol was used to ensure homogeneity in data
acquisition across different scanners. The protocol
included a high resolution 3D T1-weighted ultrafast
gradient echo volume (voxel size 1.1 × 1.1 × 1.1 mm3)
and axial proton density T2-weighted fast spin
echo images based on the ADNI study protocol
(http://adni.loni.ucla.edu/). Full details have been pre-
viously reported [20]. Quality control was carried out
using previously described criteria for scanner related
phantom work and to ensure adequate quality control
of the T1-weighted volume images such as avoidance
of wraparound artefacts and minimal levels of sub-
ject motion [20–22]. The Freesurfer analysis pipeline
(version 5.1.0) was used to produce left and right hip-
pocampal volumes for each subject. Raw hippocampal
volumes and hippocampal volumes normalized by
their respective intracranial volumes were determined
[23] as detailed in previous publications [24, 25].
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Table 1
Demographic and cognitive characteristics of carriers and non-carriers of the APOE 4 allele
ApoE 4 ApoE 4 t-value p ApoE 2 ApoE 2 t-value p
carriers non-carriers carriers non-carriers
(n = 343) (n = 1069) (n = 212) (n = 1200)
Age (years) 14.44 ± 0.40 14.45 ± 0.41 −0.104 0.917 14.41 ± 0.39 14.45 ± 0.41 −1.248 0.212
Gender (Male/Female) 169/174 534/535 – 0.852 114/98 589/611 – 0.233
BMI 20.86 ± 3.27 20.71 ± 3.56 0.673 0.501 20.72 ± 3.26 20.75 ± 3.53 −0.126 0.900
Verbal IQ 111.29 ± 14.84 111.29 ± 15.51 −0.003 0.997 110.26 ± 15.56 111.48 ± 15.31 −1.06 0.289
Performance IQ 107.84 ± 13.93 107.54 ± 14.47 0.336 0.737 106.89 ± 14.58 107.74 ± 14.30 −0.80 0.424
CANTAB SWM strategy 31.10 ± 5.41 31.22 ± 5.42 −0.336 0.737 31.36 ± 5.20 31.16 ± 5.46 0.490 0.367
Normalized R hippocampus∗ 4351.8 ± 436.9 4305.1 ± 474.4 – 0.289 4332.4 ± 504.9 4313.6 ± 458.8 – 0.103
Normalized L hippocampus∗ 4226.0 ± 504.1 4224.2 ± 475.3 – 0.406 4232.4 ± 518.2 4234.7 ± 476.3 – 0.357
Raw R hippocampus 4351.8 ± 436.9 4305.1 ± 474.4 – 0.074 4332.4 ± 504.9 4313.6 ± 458.8 – 0.893
Raw L hippocampus 4226.0 ± 504.1 4224.2 ± 475.3 – 0.111 4232.4 ± 518.2 4234.7 ± 476.3 – 0.564
Values represent Mean ± Standard Deviation. A p-value of 0.05 was considered significant for all tests. Continuous variables were inspected using
parametric t-tests (t-value) and categorical variables were inspected using fisher exact tests. Hippocampal volume differences were examined
using ANCOVA models which co-varied for age, gender, and site ID. ∗Normalized hippocampal volumes (Hippocampal volume/intracranial
volume) were analyzed but raw hippocampal volumes are reported in mm3. BMI, body mass index; Verbal IQ, verbal intelligence scale;
Performance IQ, performance intelligence scale; CANTAB SWM strategy; spatial working memory task score.
Table 2
Dose-dependent effects of ApoE 4 and ApoE 2 allelic status on hippocampal volumes
Right hippocampal volume (mm3) p Left hippocampal volume (mm3) p
ApoE 4 status
ApoE 4 allele = 0 (n = 1069) 4305.0 ± 474.4 0.283 4224.2 ± 475.3 0.399
ApoE 4 allele = 1 (n = 321) 4351.2 ± 431.1 – 4226.4 ± 502.1 –
ApoE 4 allele = 2 (n = 22) 4360.9 ± 525.7 – 4260.2 ± 545.5 –
ApoE 2 status
ApoE 2 allele = 0 (n = 1200) 4313.6 ± 458.8 0.132 4234.7 ± 476.3 0.489
ApoE 2 allele = 1 (n = 199) 4343.1 ± 512.1 – 4247.0 ± 520.6 –
ApoE 2 allele = 2 (n = 13) 4168.4 ± 351.3 – 4008.2 ± 438.6 –
Values represent Mean ± standard deviation. Comparisons were made using ANCOVA, and models were adjusted for age, gender, and site ID.
Blood samples were collected for DNA analysis
and extraction from each subject in the study. Sam-
ples were subsequently genotyped using the Illumina
Quad 610 and 660 arrays (Illumina, San Diego, CA,
USA) [20]. Two ApoE single nucleotide polymor-
phisms, rs429358 (T, C) and rs7412 (C, T), were used
to identify 3 allelic variants of ApoE (2, 3, and 4)
in order to define a subject’s genotype.
The R statistical software environment, version
2.15.2, was used to perform all statistical analy-
ses. To compare demographic statistics (age, gender,
CANTAB SWM strategy scores, verbal and perfor-
mance IQ), Fisher exact tests and two sample t-tests
were conducted. A generalized linear model was
used, adjusting for age and gender, to determine hip-
pocampal volume differences between carriers and
non-carriers of the ApoE 4 and 2 alleles and possible
dose-dependent effects of each allele on hippocampal
volume. Comparisons of the ApoE 4 and 2 alle-
les were also conducted using a previously described
asymmetry index (AI) [26] for the hippocampus and
were tested using one-way ANOVA.
RESULTS
Healthy adolescents possessing either the ApoE
4 or 2 alleles did not significantly differ in
terms of demographics (Table 1). No hippocampal
volume differences were observed between carriers
and non-carriers of the ApoE 4 allele (right hip-
pocampus: F = 22.88, p = 0.289, left hippocampus:
F = 18.9, p = 0.406) or the 2 allele (right hip-
pocampus: F = 23.42, p = 0.103, left hippocampus:
F = 18.96, p = 0.357). These results were consis-
tent when tests were repeated on raw hippocampal
volumes (Table 1). No significant differences in
the asymmetry index for the hippocampus were
observed between ApoE 4 carriers (AI = 2.23 ± 9.40)
and non-carriers (AI = 1.90 ± 10.27) (p = 0.591) and
ApoE 2 carriers (AI = 2.36 ± 11.01) and non-carriers
(AI = 1.92 ± 9.89) (p = 0.547). Furthermore, no evi-
dence of a dose-dependent effect of ApoE 4 or
2 alleles on hippocampal volume and hippocampal
asymmetry were established (Table 2). Direct com-
parisons of memory and IQ performance against both
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2 and 4 genotype did not produce any significant
results.
DISCUSSION
In this study, a large cohort of young adolescents
was used to compare the effects of different ApoE gene
polymorphisms on hippocampal volume. Contrary to
some recent studies [2, 13], no hippocampal volume
differences were observed between carriers and non-
carriers of the ApoE 4 allele, a major genetic risk
factor for the development of late-onset AD. Studies
that have demonstrated an ApoE 4 genotypic effect
on structural brain phenotypes such as the hippocam-
pus, entorhinal cortex, and other gray matter structures,
have generally done so using older non-demented and
healthy middle-aged individuals [27–32].
In healthy adults and elderly subjects, a normal
asymmetry of the hippocampus exists with the right
hippocampus larger than the left [33, 34]. Previous
studies have suggested that alteration of asymmetry
is associated with the ApoE 4 genotype [26, 35] and
is progressively reduced in AD patients possessing the
4 allele [36]. In the current study, no differences in
hippocampal asymmetry were found between carriers
and non-carriers of the ApoE 4 and 2 alleles.
The possibility of a gene dose-dependent effect of
ApoE 4 was also investigated. Although the neu-
roanatomic effects of ApoE 4 have been extensively
studied [15, 37, 38], even less is known about the
deleterious effects associated with the presence of
two 4 alleles in children and adolescents. However,
direct comparisons of 4 allele dosages in our cohort
showed no differences in subject’s hippocampal vol-
umes, despite a previous study suggesting a linearly
proportional rate of hippocampal atrophy to allele load
[39].
One possible explanation for our findings are that
ApoE 4 genotype exerts a quiescent effect on the hip-
pocampus, and as a result, neuroanatomic effects of
the 4 allele in this region may lie dormant in young
adolescents and gradually become more salient in ear-
lier adulthood. Evidence of this gradual effect can be
seen in studies that observe early structural changes in
volumes of gray matter [2, 40], as well as differences
in white matter integrity [41, 42] among 4 carriers
aged 21 and above.
Prior studies comparing the effects of ApoE poly-
morphisms on brain imaging phenotypes have yielded
equivocal findings; with some presenting no evidence
of an4 genotypic effect on gray matter volumes [3, 43,
44], and others suggesting an antagonistic pleiotropic
effect of the gene during neuronal development [45,
46]. Although a definitive conclusion has not been
drawn, this could be due to differences in sample size,
image pre-processing methods, and a lack of sample
diversity or ethnic homogeneity.
Structural MRI studies have examined perinatal
brain development in infants [47, 48] with ApoE
4 found to predict reduced temporal cortex vol-
umes. A confound of this study was that subjects
were enriched for parents with psychiatric conditions,
several of which are characterized by reduced hip-
pocampal volume. Although such studies provide a
better understanding of the perinatal effects associated
with brain development, adolescence is also a period
in which neurobiological changes may influence asyn-
chronous brain maturation [49, 50].
Regional differences in hippocampal volume
between ApoE 2 carriers and non-carriers were not
found. Hence no evidence of a 2 protective effect was
established. The putative protective effect of ApoE 2
remains a matter of debate and has generated contra-
dictory findings. Some volumetric MRI studies do not
support a disease staving protective effect in healthy
older subjects [51, 52], however, postmortem exami-
nations have shown less AD-related neuropathological
changes in 2 carriers relative to 3 homozygotes [53].
Only one study [19] was able to establish a protective
effect of the 2 variant.
Direct comparisons of memory and IQ performance
against the4 genotype also did not produce any signif-
icant results. However, as only a single test of cognition
from the CANTAB battery was assessed, we cannot
definitively exclude the possibility of a 4 genotypic
effect on cognitive function. Nevertheless, the finding
that ApoE 4 allelic status does not relate to intelli-
gence and cognitive function fits with previous studies
reporting little or no effect of the 4 allele on working
memory and intellectual capacity [54, 55].
In summary, this study suggests that hippocampal
volume differences associated with ApoE 4 and 2
are not evident in 14-year olds, and that neuroanatomic
effects of these variants may only become apparent
later in life.
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